Targeting NAD+ biosynthesis overcomes panobinostat and bortezomib-induced malignant glioma resistance

To improve therapeutic responses in glioma patients, new combination therapies that exploit a mechanistic understanding of the inevitable emergence of drug resistance are needed. Intra-tumoral heterogeneity enables a low barrier to resistance in individual glioma patients. We reasoned that targeting...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Mol Cancer Res
Главные авторы: Jane, Esther P., Premkumar, Daniel R., Thambireddy, Swetha, Golbourn, Brian, Agnihotri, Sameer, Bertrand, Kelsey C., Mack, Stephen C., Myers, Max I., Chattopadhyay, Ansuman, Taylor, D. Lansing, Schurdak, Mark E., Stern, Andrew M., Pollack, Ian F.
Формат: Artigo
Язык:Inglês
Опубликовано: 2020
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7335346/
https://ncbi.nlm.nih.gov/pubmed/32238439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1541-7786.MCR-19-0669
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы